The invention relates to a method and a pharmaceutical formation for improving the cellular uptake of nucleic acids, particularly nucleic acid agents.
It is based on the novel finding that nucleic acids modified in a particular way improve the cellular uptake of other nucleic acids, particularly double-stranded RNA (siRNA) and consequently act as transporter nucleic acids.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
